Machine Learning

As AI-powered crime surges, DataVisor appoints scaling expert Patrick Harr to lead the charge, betting on AI-native defense to win the war on fraud.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

Sensorium Therapeutics advances SNTX-2643, a novel anxiety drug, while adding a new CMO and an expert advisory board to guide its clinical journey.

A new AI-powered screening system at LaGuardia's Terminal B promises frictionless security, but can the tech firm behind it balance growth with finances?

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

A new survey reveals 4 in 5 tech leaders feel pressured to exaggerate AI success, creating a trillion-dollar paradox of high spending and low returns.

As AI speeds up coding, quality suffers. Checksum's new autonomous agent generates and self-heals tests to close the gap without human intervention.

With a new CCO known for creating unicorns, Ideon Technologies aims to revolutionize mining with subsurface imaging powered by particles from deep space.

The revived MoviePass partners with 5,000 independent theaters, a landmark deal that could save local cinemas and secure the subscription service's future.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

A new partnership between TD2 Oncology and Panome Bio aims to merge clinical expertise with deep multi-omics data to accelerate personalized cancer therapies.

Ocean data startup Coastal Measures secures $260K from Maine Angels, establishing its Kittery HQ and bolstering Maine's role as a climate tech hub.

A landmark partnership between Certis and IntBot aims to deploy socially intelligent humanoid robots across Singapore, heralding a new era of human-robot collaboration.

John Theurer Cancer Center presents breakthroughs in CAR-T, ADCs, and health equity at ASCO, offering new hope for patients worldwide.

Prezent Vivo and Nested Knowledge partner to close the 'insight-to-action' gap, delivering AI-powered intelligence to pharma teams at unprecedented speed.

Two top executives at nonprofit Riverside Research are up for major awards, signaling a powerful new model for national security innovation.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

An upcoming tech event has drawn nearly 20,000 retailers, revealing a desperate need to fix broken, manual contract processes with AI technology.

With new funding from Bregal Sagemount, LSPedia is set to advance its AI tools, moving beyond compliance to build a smarter, safer pharma supply chain.